Menicon Z Material receives further FDA clearance

Menicon Z (tisilfocon A) gas permeable contact lens material from by Menicon Co., Ltd. received an expanded indication from the U.S. Food and Drug Administration for management of irregular corneal conditions (in non-diseased eyes) including keratoconus, pellucid marginal degeneration, post penetrating keratoplasty, post radial keratotomy and post LASIK surgery.

The expanded indication positions Menicon Z as a hyper-oxygen delivery (Dk 163) option for the management of irregular corneal conditions. Menicon Z is currently available to authorized Menicon Z manufacturers in standard sized blanks. Within the coming weeks, the company will release a large diameter, 16.5mm blank for sale to authorized laboratories.

Graham Avery, Sales & Marketing Director of DTCL in the UK commented, 'This further indication for Menicon Z material will allow us to offer the Z material in a number of larger diameter lens designs, including scleral lens designs. We are currently evaluating a number of different scleral lens designs for future release to ECP's, in this segment of the market that is attracting increasing interest from eye care practioners wanting to establish themselves as speciality contact lenses fitters. With Menicon Z material offering an unsurpassed level of oxygen delivery and in combination with larger diameter lens designs, we hope eye care practioners will recognise the added value of offering Menicon Z material to their patients.'